Human medicines European public assessment report (EPAR): Lemtrada, alemtuzumab, Date of authorisation: 12/09/2013, Revision: 24, Status: Authorised

Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) meetings

Clinical Trials Information System (CTIS) Bitesize Talk: How to submit a transitional trial in CTIS, Online, Broadcast, from 29 February 2024, 16:30 (CET) to 29 February 2024, 18:00 (CET)

Human medicines European public assessment report (EPAR): Granupas (previously Para-aminosalicylic acid Lucane), para-aminosalicylic acid, Date of authorisation: 07/04/2014, Revision: 11, Status: Authorised

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - April 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 April 2024, 09:00 (CEST) to 23 April 2024, 10:00 (CEST)

Agenda of the CHMP meeting 22-25 April 2024

Human medicines European public assessment report (EPAR): Nintedanib Accord, nintedanib, Date of authorisation: 19/04/2024, Status: Authorised

Human medicines European public assessment report (EPAR): Lymphoseek, tilmanocept, Date of authorisation: 19/11/2014, Revision: 8, Status: Authorised

Paediatric Oncology Strategy Forum: 24-25 October 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 October 2024 to 25 October 2024

Product Management Service (PMS) Info-Day, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 April 2024, 09:15 (CEST) to 16 April 2024, 17:30 (CEST)